luisa iommarini
Department of Pharmacy and Biotechnology, University of Bologna
Bologna, Italy
Review Editor
Molecular and Cellular Oncology
Department of Pharmacy and Biotechnology, University of Bologna
Bologna, Italy
Review Editor
Molecular and Cellular Oncology
Federal University of Alfenas
Alfenas, Brazil
Review Editor
Molecular and Cellular Oncology
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Molecular and Cellular Oncology
University of Florence
Florence, Italy
Review Editor
Molecular and Cellular Oncology
Tel Aviv University
Tel Aviv, Israel
Review Editor
Molecular and Cellular Oncology
St Vincents Institute of Medical Research, University of Melbourne
Fitzroy, Australia
Review Editor
Molecular and Cellular Oncology
University of Florida
Gainesville, United States
Review Editor
Molecular and Cellular Oncology
Institute for Research in Biomedicine
Barcelona, Spain
Review Editor
Molecular and Cellular Oncology
East Tennessee State University
Johnson City, United States
Review Editor
Molecular and Cellular Oncology
Soochow University
Suzhou, China
Review Editor
Molecular and Cellular Oncology
Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Molecular and Cellular Oncology
Wayne State University
Detroit, United States
Review Editor
Molecular and Cellular Oncology
Mount Sinai Medical Center
Miami Beach, United States
Review Editor
Molecular and Cellular Oncology
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Molecular and Cellular Oncology
University of Massachusetts Amherst
Amherst, United States
Review Editor
Molecular and Cellular Oncology
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Review Editor
Molecular and Cellular Oncology